Document is current
Any future updates will be listed below
-
Authors
Simões, Bruno M. https://orcid.org/0000-0003-1253-6657
Santiago-Gómez, Angélica
Chiodo, Chiara
Moreira, Tiago
Conole, Daniel https://orcid.org/0000-0002-3389-8377
Lovell, Scott
Alferez, Denis
Eyre, Rachel
Spence, Katherine
Sarmiento-Castro, Aida
Kohler, Bertram
Morisset, Ludivine
Lanzino, Marilena
Andò, Sebastiano
Marangoni, Elisabetta
Sims, Andrew H. https://orcid.org/0000-0001-9082-3665
Tate, Edward W. https://orcid.org/0000-0003-2213-5814
Howell, Sacha J. https://orcid.org/0000-0001-8141-6515
Clarke, Robert B. https://orcid.org/0000-0001-5407-3123
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (IS-BRC-1215-20007, IS-BRC-1215-20007, IS-BRC-1215-20007)
Breast Cancer Now (MAN-Q2)
National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/T001267/1)
RCUK | Medical Research Council (MR/K501311/1)
- License Information
-
More Information
Article History
Received: 21 February 2020
Revised: 13 May 2020
Accepted: 15 May 2020
First Online: 30 May 2020
Compliance with ethical standards
:
: EWT is a founder, Director, and shareholder of Myricx Pharma Ltd.
